Loading...
Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases
Establishing a definitive diagnosis of Cushing disease (CD), given its clinical and biochemical heterogeneity, initiating effective treatment to control the effects of hypercortisolism, and managing recurrence are challenging disease aspects to address. Mifepristone is a competitive glucocorticoid r...
Saved in:
| Published in: | Clin Med Insights Endocrinol Diabetes |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7940725/ https://ncbi.nlm.nih.gov/pubmed/33746521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179551421994102 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|